This project has received funding from the European Union’s 7th Framework Programme for research, technological development and demonstration under grant agreement no 611709
Subcribe to our mailing list
> Delivering value to European SMEs and entrepeneurs
Follow this project on F6S
Follow us on twitter
Loading Twitter messages...
Interview with Omri Shor, CEO of MediSafe
24. February 2015
MediSafe™ is an award-winning, data-driven Medication Management Platform - Designed to understand the personal causes of non-adherence and use this information in real time to create better
patient engagement and raise medication adherence. MediSafe™ helps reduce costs, and increases both the health and financial outcomes for everyone; patients and their families, pharmaceutical
companies, PBMs, health care providers and insurers.
MediSafe recently raised $6M in series A funding. Omri says: “Investors care about two things: the product market fit and the business model fit”
For the GET project Pascal Lardier interviewed Omri Shor, CEO of MediSafe.